Restructuring hitting pharmaceutical sector

Korea’s pharmaceutical sector is headed for a fresh round of restructuring, with many companies pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook.

Domestic and foreign drug firms are taking steps to reduce their workforces including salespeople as they brace for lower earnings due to the imminent government’s plan to slash drug pric...